Blog by Professor Frédéric Barbut, medical microbiologist, Assistance Publique-Hôpitaux de Paris, hôpital Saint-Antoine, Paris

Did you know that we all carry many millions of bacteria on our hands? Anything between 100 to 1,000,000 per square centimetre of skin! But before you start to panic, rest assured that many of these bacteria occur naturally, along with fungi and viruses, and are normally harmless (or ‘not pathogenic’ to use the scientific term). They are known as ‘resident microflora’ and can actually be beneficial in protecting us from infection. Common strains include Staphylococcus and Micrococcus.

M-Trace® Electronic Test Record Software offers digital cleanroom-friendly solution for sterility testing
Digitizes pharmaceutical microbial quality control workflows
Enables complete, real-time, comprehensive data traceability and regulatory compliance, reducing deviations and human error

Partnership to facilitate collaborative research in academia and industry to further progress in life sciences.

Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Multi-dimensional program to build local research capability and startup ecosystem as well as joint R&D projects
Further example of Merck’s close cooperation with Korea, following the recent € 300 million bioprocessing investment in Daejeon

Global software developer eschbach, the provider of the Shiftconnector® enterprise manufacturing platform for the process industry, has a module, Shiftconnector® Equipment Hub. Designed for the pharmaceutical industry, the Equipment Hub ensures data integrity, simplifies search and retrieval across logs for audits and inspections, and streamlines compliance reporting.

High-flow, biocompatible PBT grade to be shown at NPE2024

New VALOX™ HX325HP resin meets international standards of biocompatibility and change management.
This unreinforced polybutylene terephthalate (PBT) resin has predictable processing and performance properties, including excellent mold release, flexible sterilization options and high environmental stress cracking (ESC) resistance.
It addresses a growing need for medical devices that enable more-convenient and personalized insulin administration and glucose monitoring by patients.

German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony
Research center to accelerate biopharmaceutical product development
Part of Merck’s € 1.5 billion investment program in Darmstadt by 2025

Page 1 of 5

Meet Our Sponsors

Latest Sponsor News

Articles Most Read

Latest News


Articles View Hits

Who's Online

We have 23 guests and no members online